DIREXION SHS ETF TR - HEALTHCARE BUL (CURE)

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Equity / HEALTHCARE BUL
Symbol
CURE
Price per share
$83.52
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
160,603
Total reported value
$13,403,499
% of total 13F portfolios
0%
Share change
+72,208
Value change
+$6,201,049
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) has 22 institutional shareholders filing 13F forms. They hold 160,603 shares. .

Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 160,603 $13,403,499 +$6,201,049 8,352% 22
2025 Q2 104,829 $8,738,642 -$2,121,035 7,882% 21
2025 Q1 119,630 $12,749,419 -$3,651,625 10,661% 21
2024 Q4 162,215 $14,967,674 +$2,061,776 9,229% 23
2024 Q3 117,641 $14,975,249 -$10,934,695 13,318% 20
2024 Q2 209,029 $24,832,086 -$619,320 11,681% 21
2024 Q1 212,892 $26,661,184 +$106,676 12,545% 23
2023 Q4 212,898 $21,651,140 +$391,279 10,174% 21
2023 Q3 211,193 $18,695,500 +$3,183,011 8,853% 20
2023 Q2 172,863 $17,292,257 +$3,960,921 10,001% 20
2023 Q1 111,129 $10,668,334 +$5,851,533 9,600% 13
2022 Q4 48,370 $5,550,191 -$3,270,942 11,476% 20
2022 Q3 75,620 $6,384,394 +$4,299,090 8,444.08% 18
2022 Q2 24,736 $2,549,132 -$6,735,919 10,308.27% 17
2022 Q1 82,130 $10,714,439 -$2,026,082 13,045.1% 22
2021 Q4 93,191 $13,512,085 +$5,665,141 14,497.56% 20
2021 Q3 59,622 $6,415,296 +$3,553,189 10,743.22% 19
2021 Q2 26,189 $2,785,000 -$1,481,857 10,457.56% 14
2021 Q1 90,189 $7,533,644 -$4,130,827 8,351.44% 15
2020 Q4 144,746 $11,147,104 +$4,022,795 7,700.39% 17
2020 Q3 92,309 $5,870,731 -$7,543,034 6,302.33% 13
2020 Q2 215,776 $11,724,759 +$1,931,785 5,432.82% 15
2020 Q1 180,011 $7,164,157 -$2,162,961 3,983.33% 13
2019 Q4 235,161 $17,326,593 +$171,216 7,367.71% 16
2019 Q3 234,450 $11,856 -$5,214 5.06% 17
2019 Q2 328,279 $18,426 -$314 5.61% 16
2019 Q1 262,640 $14,599,783 +$3,499,448 5,558.14% 12
2018 Q4 199,383 $9,488,000 +$2,674,821 4,759.01% 13
2018 Q3 141,882 $9,454,545 -$4,469,599 6,663.19% 13
2018 Q2 248,899 $11,283,000 +$3,462,492 4,536.72% 18
2018 Q1 173,165 $7,453,000 +$2,373,455 4,304.51% 16
2017 Q4 116,193 $5,414,000 -$3,613,483 4,660.28% 14
2017 Q3 193,068 $8,762,000 -$1,412,493 4,548.31% 9
2017 Q2 238,248 $9,943,260 +$1,840,958 4,170.59% 13
2017 Q1 181,464 $6,253,820 -$1,133,089 3,444.95% 13
2016 Q4 239,800 $6,613,000 -$232,500 2,757.18% 14
2016 Q3 3,103.45% 1
2016 Q2 0 $0 -$167,840 3,073.53% 1
2016 Q1 159,786 $4,337,840 -$1,605,157 2,714.61% 12
2015 Q4 211,884 $7,076,400 +$2,802,828 3,339.75% 12
2015 Q3 127,415 $3,369,280 -$6,207,309 2,644.27% 10
2015 Q2 262,705 $10,329,920 +$6,738,740 3,932.01% 11
2015 Q1 69,646 $10,242,669 -$2,877,026 14,707.8% 13
2014 Q4 96,637 $12,023,156 +$8,809,291 12,442.74% 14
2014 Q3 23,762 $2,454,980 -$6,256,051 10,329.34% 7
2014 Q2 94,498 $8,468,740 +$1,164,730 8,961.5% 9
2014 Q1 83,752 $6,714,255 +$2,631,708 8,016.36% 6